Revlon, Inc.
Form 483 issued January 12, 2024 · Oxford, North Carolina
- Investigator
- Martrice A. Packer
- Observations
- 3
- Pages
- 3
- FEI number
- 1021184
In short: On January 12, 2024, FDA issued a Form 483 with 3 observations to Revlon, Inc. in Oxford, North Carolina (FEI 1021184). The investigator was Martrice A. Packer. Most observations concern facilities & equipment and laboratory controls.
At a glance
Facilities & equipment and laboratory controls account for 2 of 3 observations.
What FDA observed
Preview: the opening words of each observation- 01
Equipment and utensils are not cleaned and sanitized at appropriate intervals to prevent contamination that would…
- 02
Laboratory controls do not include the establishment of scientifically sound and appropriate specifications and test procedures…
- 03
Inspection of the packaging and labeling facilities immediately before use is not done to assure that…
This inspection in context
Martrice A. Packer
6 documents · 2022–2024
Cites FDCA 501(a)(2)(A) (insanitary conditions) more than any other section. Most of their documents are for sites in Alabama.
The firmRevlon, Inc. history
All 2 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sOther sites cited under 211.67(a)
See how FDA wrote the same problem up elsewhere.
Questions about this 483
What did FDA find at Revlon, Inc.?
FDA listed 3 observations on this Form 483, mostly about facilities & equipment, laboratory controls and packaging & labeling. The opening words of each observation are shown on this page.
Who inspected Revlon, Inc.?
Martrice A. Packer is named on this Form 483. Each investigator has a profile showing what they cite most.
When was Revlon, Inc. inspected by FDA?
This Form 483 is dated January 12, 2024.
How do I get the full Form 483 for Revlon, Inc.?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.